We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+8.15%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$287B
AUM Growth
+$27.6B
Cap. Flow
+$6.59B
Cap. Flow %
2.29%
Top 10 Hldgs %
12.98%
Holding
8,864
New
808
Increased
4,306
Reduced
2,684
Closed
688

Sector Composition

Rank Sector Weight
1 Technology 9.82%
2 Financials 7.38%
3 Healthcare 6.65%
4 Consumer Discretionary 5.46%
5 Industrials 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CMTL icon
4001
Comtech Telecommunications
CMTL
$51.5M
$1.24M ﹤0.01%
35,044
+10,850
+45% +$373K
STEW
4002
SRH Total Return Fund
STEW
$1.82B
$1.24M ﹤0.01%
105,549
+3,496
+3% +$39.8K
IMKTA icon
4003
Ingles Markets
IMKTA
$1.62B
$1.24M ﹤0.01%
26,102
+8,330
+47% +$355K
LMNX
4004
DELISTED
Luminex Corp
LMNX
$1.24M ﹤0.01%
53,497
+24,151
+82% +$498K
NUMG icon
4005
Nuveen ESG Mid-Cap Growth ETF
NUMG
$368M
$1.24M ﹤0.01%
35,101
+7,266
+26% +$246K
NHC icon
4006
National Healthcare
NHC
$3.46B
$1.23M ﹤0.01%
14,272
+2,856
+25% +$239K
SBLK icon
4007
Star Bulk Carriers
SBLK
$3.17B
$1.23M ﹤0.01%
104,509
-9,402
-8% -$102K
VNDA icon
4008
Vanda Pharmaceuticals
VNDA
$304M
$1.23M ﹤0.01%
75,179
-4,209
-5% -$63.6K
IYLD icon
4009
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
$1.23M ﹤0.01%
48,234
-4,521
-9% -$114K
ADX icon
4010
Adams Diversified Equity Fund
ADX
$3.21B
$1.23M ﹤0.01%
78,057
+3,893
+5% +$61.9K
MSGN
4011
DELISTED
MSG Networks Inc.
MSGN
$1.23M ﹤0.01%
70,756
+6,998
+11% +$116K
LGI
4012
Lazard Global Total Return & Income Fund
LGI
$240M
$1.23M ﹤0.01%
74,245
+30,311
+69% +$476K
IGD
4013
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$522M
$1.23M ﹤0.01%
198,352
-6,046
-3% -$36.9K
LIT icon
4014
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$1.23M ﹤0.01%
44,790
-2,463
-5% -$62.9K
CFMS
4015
DELISTED
Conformis, Inc. Common Stock
CFMS
$1.23M ﹤0.01%
32,667
+2,887
+10% +$137K
EXTR icon
4016
Extreme Networks
EXTR
$3.09B
$1.22M ﹤0.01%
166,069
-111,929
-40% -$785K
STMP
4017
DELISTED
Stamps.com, Inc.
STMP
$1.22M ﹤0.01%
14,662
+13,106
+842% +$1.09M
KIN
4018
DELISTED
Kindred Biosciences, Inc.
KIN
$1.22M ﹤0.01%
144,079
+23,262
+19% +$182K
OPPE
4019
WisdomTree European Opportunities Fund
OPPE
$295M
$1.22M ﹤0.01%
37,113
+8,893
+32% +$283K
CVNA icon
4020
PUT
Carvana
CVNA
$81.5B
$1.22M ﹤0.01%
+66,000
New +$1.1M
FOF icon
4021
Cohen & Steers Closed End Opportunity Fund
FOF
$382M
$1.22M ﹤0.01%
90,561
-1,994
-2% -$26.2K
P
4022
Everpure Inc
P
$32.6B
$1.22M ﹤0.01%
71,006
-11,702
-14% -$207K
PRVL
4023
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
$1.22M ﹤0.01%
+76,764
New +$979K
SP
4024
DELISTED
SP Plus Corporation
SP
$1.21M ﹤0.01%
28,598
+10,291
+56% +$433K
CHIQ icon
4025
Global X MSCI China Consumer Discretionary ETF
CHIQ
$127M
$1.21M ﹤0.01%
65,493
+6,201
+10% +$109K

Similar funds

UBS Group's Q4 2019 Portfolio in Review

As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q4 2019 filing shows 808 new, 4,306 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.

By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
  • UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
  • UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
  • UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
  • UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
  • UBS Group opened 808 new positions and closed 688 in Q4 2019.
  • UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.

Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.